Kestine Smelt (Ebastine)

Ebastine works by selectively antagonising peripheral H1‑histamine receptors. By blocking these receptors, it prevents histamine released during allergic reactions from binding, thereby inhibiting the cascade that causes vasodilation, increased vascular permeability, and sensory nerve activation, which reduces itching, swelling and nasal symptoms.

The dosage of Kestine Smelt is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms and overall health status. Physicians typically follow approved dosing guidelines, but the exact regimen should be confirmed with the prescriber and not inferred from product information alone.

Safety data for ebastine in pregnancy and lactation are limited. It should only be used during pregnancy or while breastfeeding if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and after consultation with a qualified healthcare provider.

To order Kestine Smelt, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with first‑generation antihistamines, ebastine (Kestine Smelt) offers a lower risk of sedation and anticholinergic side effects because it does not readily cross the blood‑brain barrier. Within the second‑generation class, its efficacy in controlling allergic rhinitis and urticaria is comparable to agents such as cetirizine or loratadine, while its safety profile remains favourable.

Kestine Smelt should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Kestine Smelt is administered orally as a tablet. The tablet should be swallowed whole with a glass of water, preferably at the same time each day, unless otherwise directed by a healthcare professional.

Serious but rare risks include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, and anaphylaxis. Patients should seek immediate medical attention if they experience swelling of the face or throat, widespread rash, blistering, or signs of a systemic allergic reaction.

Kestine Smelt should be avoided in individuals with known hypersensitivity to ebastine or any of the tablet’s excipients. Caution is also advised for patients with severe hepatic impairment, and it is generally not recommended for use in pregnant or breastfeeding women without specialist advice.